Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

As Policymakers Begin to Crack Down on Xylazine (Tranq), They Should Get Ready for Medetomidine

by May 8, 2024
May 8, 2024
As Policymakers Begin to Crack Down on Xylazine (Tranq), They Should Get Ready for Medetomidine

Jeffrey A. Singer

The iron law of prohibition—the harder the law enforcement, the harder the drug—is the reason why, in recent years, fentanyl has replaced heroin, the veterinary tranquilizer xylazine began being added to fentanyl to make more potent and deadly tranq, and, more recently, the synthetic opioid isotonitazene (“iso” or “tony”) has made its debut in the dangerous black market that prohibition fuels. As policymakers keep doubling down on law enforcement strategies to prosecute the futile war on drugs, they provide greater incentives for drug trafficking organizations to create new and more potent drugs and drug combinations to meet market demand.

State lawmakers have begun to crack down on xylazine by designating it a controlled substance. Florida, Ohio, Pennsylvania, and West Virginia have already done so, and several other state legislatures are also considering doing so. The American Veterinary Medical Association has called on Congress to add xylazine to the schedule of controlled substances, and a bill before Congress that would designate xylazine as a Schedule III drug has drawn bipartisan support.

Enter medetomidine/​dexmedetomidine, or Domitor. Law enforcement first detected this veterinary tranquilizer in fentanyl, fentanyl analogs, and cocaine samples seized in Maryland in 2022. The DEA has since detected it in St. Louis and in clandestine laboratory seizures in Florida, Ohio, and Canada.

Like xylazine, medetomidine is a potent veterinary anesthetic/​analgesic. Estimated to be 200 times more powerful than xylazine, PAGround​hogs​.org, a Pennsylvania non‐​profit harm‐​reduction drug testing organization, found it in two bags of fentanyl in Philadelphia and two dozen samples from Pittsburgh, Cambria County, and Blair County in Pennsylvania.

Look for medetomidine to become more prevalent if policymakers make it more difficult for drug traffickers to access xylazine.

Last year, in testimony before the House Judiciary Committee Subcommittee on Crime and Government Surveillance, I warned lawmakers that nitazenes were on the horizon and that doubling down on law enforcement to address the fentanyl overdose crisis may make a nitazene crisis come sooner. Instead, Congress passed the FEND OFF Fentanyl Act, which President Biden recently signed. Intended to put more pressure on the makers of illicit fentanyl and fentanyl precursors, the new law is likely to incentivize drug trafficking organizations to switch more rapidly to nitazenes, the precursors of which will be easy to come by but harder for law enforcement to track.

As is usually the case in the war on drugs, policymakers are fighting the last battle while drug trafficking organizations are opening new fronts.

0
FacebookTwitterGoogle +Pinterest
previous post
Republicans keep pressure on NPR and controversial CEO amid political bias scandal
next post
No, Canada Did Not Recriminalize Drugs in British Columbia

You may also like

Bank and Crypto Runs: F(ac)TX vs Fiction

November 21, 2022

Steve Ballmer’s New Public Sector 10‑K Report Illustrates...

April 20, 2023

San Francisco Should Stop Sharing the Ankle Monitor...

May 30, 2024

Don’t Conflate US and Israeli Border Security Challenges

October 18, 2023

WSJ Ed Board Knifes Fourth Amendment, Betrays Journal’s...

March 27, 2024

Cato Tax Bootcamp: The Quest for Radical Tax...

January 30, 2025

101 Late Fees Charged by the Government

May 17, 2024

The Hamas-Israel War

October 15, 2023

Fischer v. US: Court Clarifies Ban on Obstructing...

June 28, 2024

Federal Court Rules FISA Section 702 “Back Door”...

January 22, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Musk feud presents ‘unprecedented’ dynamic compared to past Trump disputes: expert

      June 7, 2025
    • Snub of Musk’s NASA nominee ally preceded sudden ‘big, beautiful bill’ criticism, Trump feud

      June 6, 2025
    • Supreme Court rules DOGE can access Social Security information

      June 6, 2025
    • US sanctions money laundering network aiding Iran as regime faces nuclear reprimand at IAEA

      June 6, 2025
    • From Tariffs to Tech: Where Smart Money’s Moving Right Now

      June 6, 2025
    • Your Weekly Stock Market Snapshot: What It Means for Your Investments

      June 6, 2025

    Categories

    • Business (8,149)
    • Investing (2,019)
    • Politics (15,556)
    • Stocks (3,134)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved